Editorial SETDB1 is a new promising target in HCC therapy Carla Cicchini, Cecilia Battistelli, Marco Tripodi Abstract Hepatocellular carcinoma (HCC), a major form of adult primary liver cancer, is the third cause of cancer-related deaths worldwide.
